Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · IEX Real-Time Price · USD
23.35
-0.67 (-2.79%)
At close: Dec 29, 2023, 4:00 PM
23.42
+0.07 (0.30%)
After-hours: Dec 29, 2023, 7:49 PM EST
Akero Therapeutics Stock Forecast
Stock Price Forecast
According to 7 stock analysts, the average 12-month stock price forecast for AKRO stock stock is $44.43, which predicts an increase of 90.28%. The lowest target is $33 and the highest is $60. On average, analysts rate AKRO stock stock as a strong buy.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 14, 2023.
Analyst Ratings
The average analyst rating for AKRO stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '23 | Aug '23 | Sep '23 | Oct '23 | Nov '23 | Dec '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 8 | 8 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +71.31% | Nov 14, 2023 |
| UBS | UBS | Strong Buy Maintains $83 → $39 | Strong Buy | Maintains | $83 → $39 | +67.02% | Oct 12, 2023 |
| JP Morgan | JP Morgan | Buy Maintains $62 → $41 | Buy | Maintains | $62 → $41 | +75.59% | Oct 11, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $64 → $40 | Strong Buy | Maintains | $64 → $40 | +71.31% | Oct 11, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $69 → $39 | Buy | Maintains | $69 → $39 | +67.02% | Oct 11, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.90
from -2.87
EPS Next Year
-3.63
from -2.90
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | n/a | 27.1M | 121.9M | 389.8M |
| Avg | n/a | n/a | n/a | 6.6M | 29.6M | 172.5M |
| Low | n/a | n/a | n/a | n/a | n/a | 61.0M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | - | - | - | - | 1,751.3% | 1,217.0% |
| Avg | - | - | - | - | 349.6% | 482.8% |
| Low | - | - | - | - | - | 106.0% |
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | -2.79 | -2.93 | -3.77 | -3.28 | -0.98 | 2.29 |
| Avg | -2.90 | -3.63 | -4.32 | -3.18 | -0.95 | 2.22 |
| Low | -3.06 | -4.20 | -5.06 | -3.06 | -0.91 | 2.14 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | - | - | - | - | - | - |
| Avg | - | - | - | - | - | - |
| Low | - | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.